Yong Lu

6PUBLICATIONS
46CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 16, 2026
T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers.

Yufei Zhang, Wei Xiong, Jianfei Qian

|Apr 03, 2025
Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss.

Liuling Xiao, Rui Duan, Wendao Liu

|Dec 15, 2023
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.

Sunny Mai, Alan Hodges, Hui-Ming Chen

|Jun 27, 2023
Distinct inflammatory Th17 subsets emerge in autoimmunity and infection.

Ronald J Bouch, Jing Zhang, Brandi C Miller

|Dec 17, 2021
Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.

Yang Liu, Lulu Wang, Qianqian Song

|Nov 02, 2021
Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells.

Gang Xue, Ziyu Wang, Ningbo Zheng

Pageof 1

Frequent Collaborators

2 joint publications

Qing Yi

2 joint publications

Qiang Wang

2 joint publications

Miao Xian

1 joint publications

Yabo Li